MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman-Tancredi, A.
Right arrow Articles by Millan, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman-Tancredi, A.
Right arrow Articles by Millan, M. J.

Vol. 58, Issue 5, 1042-1049, November 2000

Inverse Agonism and Constitutive Activity as Functional Correlates of Serotonin h5-HT1B Receptor/G-Protein Stoichiometry

Adrian Newman-Tancredi, Valérie Audinot, Celia Moreira, Laurence Verrièle, and Mark J. Millan

Departments of Psychopharmacology (A.N.-T., C.M., L.V., M.J.M.) and Molecular and Cellular Pharmacology (V.A.), Institut de Recherches Servier, Croissy-sur-Seine (Paris), France

ABSTRACT

This study evaluated the influence of receptor/G-protein (R:G) stoichiometry on constitutive activity and the efficacy of agonists, partial agonists, and inverse agonists at human (h) 5-hydroxytryphamine 1B (5-HT1B) receptors. Two Chinese hamster ovary cell lines were used; they expressed 8.5 versus 0.4 pmol h5-HT1B receptors/mg (determined by [3H]GR125,743 saturation analysis) and 3.0 versus 1.5 pmol receptor-activated G-proteins/mg [determined by guanosine-5'-O-(3-[35S]thio)-triphosphate ([35S]GTPgamma S) isotopic dilution], respectively. Thus, they displayed R:G ratios of ~3.0 (RGhigh) and ~0.3 (RGlow), respectively. In competition-binding experiments, the agonists, 5-HT and sumatriptan, displayed fewer high-affinity (HA)-binding sites and the partial agonists, BMS181,101 and L775,606, displayed decreased affinity in RGhigh versus RGlow membranes. In contrast, the inverse agonists, SB224,289 and, to a lesser extent, methiothepin, showed increased affinity. In G-protein activation experiments, both basal and 5-HT-activated [35S]GTPgamma S binding were higher in RGhigh than in RGlow membranes. Constitutive activity (determined by inhibition of basal [35S]GTPgamma S binding with GTPgamma S in the absence of receptor ligands) was more pronounced in RGhigh versus RGlow membranes, as revealed by the >5-fold greater proportion of HA sites. Correspondingly, the negative efficacy of inverse agonists was strikingly augmented, inasmuch as they suppressed approximately two-thirds of HA [35S]GTPgamma S binding in RGhigh membranes, but only approximately one-third in RGlow membranes. Furthermore, the efficacy of partial agonists was greater at RGhigh versus RGlow membranes, as estimated by their ability to enhance [35S]GTPgamma S binding. In conclusion, an increase in R:G ratios at h5-HT1B receptors was associated with an increase in relative efficacy of partial agonists and, most notably, an increase in both constitutive G-protein activation and negative efficacy of inverse agonists.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J Biomol ScreenHome page
M. F. Peters, K. S. Knappenberger, D. Wilkins, L. A. Sygowski, L. A. Lazor, J. Liu, and C. W. Scott
Evaluation of Cellular Dielectric Spectroscopy, a Whole-Cell, Label-Free Technology for Drug Discovery on Gi-Coupled GPCRs
J Biomol Screen, April 1, 2007; 12(3): 312 - 319.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
T. Kenakin
Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism
Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Zollner, M. A. Shaqura, C. P. Bopaiah, S. Mousa, C. Stein, and M. Schafer
Painful Inflammation-Induced Increase in {micro}-Opioid Receptor Binding and G-Protein Coupling in Primary Afferent Neurons
Mol. Pharmacol., August 1, 2003; 64(2): 202 - 210.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics